Chapter 8. Tumor Markers in Primary and Secondary Liver Tumors

  1. Pierre-Alain Clavien MD, Phd, FACS, FRCS Professor Chairman and
  2. Stefan Breitenstein MD
  1. Ketsia B. Pierre MD, MSCI1,2 and
  2. Ravi S. Chari MD Professor1,2

Published Online: 9 DEC 2009

DOI: 10.1002/9781444317053.ch8

Malignant Liver Tumors: Current and Emerging Therapies, Third Edition

Malignant Liver Tumors: Current and Emerging Therapies, Third Edition

How to Cite

Pierre, K. B. and Chari, R. S. (2010) Tumor Markers in Primary and Secondary Liver Tumors, in Malignant Liver Tumors: Current and Emerging Therapies, Third Edition (eds P.-A. Clavien and S. Breitenstein), Wiley-Blackwell, Oxford, UK. doi: 10.1002/9781444317053.ch8

Editor Information

  1. Department of Surgery, Swiss Hepato-Pancreato-Biliary and Transplantation Center, University Hospital Zurich, Zurich, Switzerland

Author Information

  1. 1

    Division of Hepatobiliary Surgery and Liver Transplantation, USA

  2. 2

    Vanderbilt University Medical Center, Nashville, TN, USA

Publication History

  1. Published Online: 9 DEC 2009
  2. Published Print: 12 JAN 2010

ISBN Information

Print ISBN: 9781405179768

Online ISBN: 9781444317053

SEARCH

Keywords:

  • tumor markers in primary and secondary liver tumors;
  • goal of tumor marker research and identifying markers;
  • tumor-specific versus tumor-associated markers;
  • tumor marker utility grading worksheet;
  • Urokinase-type plasminogen activator (UPA) - serine protease, monitored by radioimmunoassay;
  • serum alpha-L-fucosidase (AFU);
  • tumor markers in metastatic liver cancer;
  • clinically established markers in liver tumors

Summary

This chapter contains sections titled:

  • Tumor markers in primary liver cancer

  • Tumor markers in m etastatic liver cancer

  • Conclusions

  • References

  • Self-assessment questions

  • Self-assessment answers